Envoy Medical (COCH) Return on Capital Employed (2021 - 2026)
Envoy Medical (COCH) posted Return on Capital Employed of 331.31% for Q1 2026, down 147.49% sequentially from 697.57% in Q4 2025, and up 24733.0% YoY from N/an in Q1 2025.
Envoy Medical (COCH) Return on Capital Employed (2021 - 2026) Analysis & Trends
Envoy Medical has reported Return on Capital Employed for 6 years, with the latest figure at 331.31% in Q1 2026.
- Quarterly Return on Capital Employed rose 24733.0% year-over-year to 331.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 331.31% (up 24733.0% YoY) and the FY2025 annual result came in at 1470.94%, up 228463.0% from the prior year.
- Return on Capital Employed slipped to 331.31% in Q1 2026 per COCH's latest filing, from 697.57% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 4414.68% in Q2 2024 and troughed at 38921.9% in Q3 2025.
- A 5-year average of 2106.41% and a median of 40.93% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed soared 445053 bps in 2024, then sank 4105011 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 3.34% in 2022, then sank by 2341 bps to 81.41% in 2023, then plunged by 707 bps to 657.35% in 2024, then surged by 206 bps to 697.57% in 2025, then sank by 147 bps to 331.31% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 331.31%, 697.57%, and 38921.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.47 Bn | 193.87 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.67 Bn | 110.45 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.38 Bn | 48.13 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.15 Bn | 32.04 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 12.08% |
| 10 | Envoy Medical | 77.49 Mn | 57.81 Mn | -227,000.00 | -165.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -165.74% |
| Mar 31, 2026 | -331.31% |
| Dec 31, 2025 | 697.57% |
| Sep 30, 2025 | -38,921.90% |
| Jun 30, 2025 | -919.39% |
| Mar 31, 2025 | -578.64% |
| Dec 31, 2024 | -657.35% |
| Sep 30, 2024 | 2,128.20% |
| Jun 30, 2024 | 4,414.68% |
| Mar 31, 2024 | -1,411.53% |
| Dec 31, 2023 | -81.41% |
| Sep 30, 2023 | -40.93% |
| Jun 30, 2023 | -35.85% |
| Mar 31, 2023 | -63.60% |
| Dec 31, 2022 | -3.34% |
| Sep 30, 2022 | -1.22% |
| Jun 30, 2022 | -1.50% |
| Mar 31, 2022 | -1.54% |
| Dec 31, 2021 | -1.41% |